Table 1 Demographics of the cohort
Complete dataset | Subset with longitudinal clinical and cognition data | |||||
|---|---|---|---|---|---|---|
Total (N = 200) | VR − (N = 72) | VR + (N = 128) | Total (N = 108) | VR − (N = 35) | VR + (N = 73) | |
Age | 61.75 ± 5.8 | 61.63 ± 5.5 | 61.82 ± 6.0 | 61.6 ± 5.9 | 62.3 ± 5.4 | 61.2 ± 6.1 |
Sex (F) | 91 (45.5%) | 23 (31.9%) | 68 (53.1%) | 48 (44.4%) | 11 (31.4%) | 37 (50.7%) |
APOE-ε4 carriership | 111 (55.5%) | 25 (34.7%) | 86 (67.2%) | 89 (60.2%) | 13 (39.4%) | 52 (76.5%) |
Clinical diagnosis (post-PET) | ||||||
SCD | 4 (2.0%) | 4 (5.6%) | n/a | n/a | n/a | n/a |
MCI | 12 (6.0%) | 11 (15.3%) | 1 (0.8%) | 8 (7.4%) | 7 (20.0%) | 1 (1.4%) |
Dementia | 184 (92.0%) | 57 (79.2%) | 127 (99.2%) | 100 (92.6%) | 28 (80.0%) | 72 (98.6%) |
Etiological diagnosis (post-PET) | ||||||
AD | 124 (62.0%) | 2 (2.8%) | 122 (95.3%) | 71 (65.7%) | 1 (2.9%) | 70 (95.9%) |
Vascular | 3 (1.5%) | 3 (4.2%) | n/a | 2 (1.9%) | 2 (5.7%) | n/a |
FTLD | 30 (15.0%) | 29 (40.3%) | 1 (0.8%) | 13 (12.0%) | 13 (37.1%) | n/a |
DLB | 11 (5.5%) | 7 (9.7%) | 4 (3.1%) | 7 (6.5%) | 4 (11.4%) | 3 (4.1%) |
ND other | 9 (4.5%) | 8 (11.1%) | 1 (0.8%) | 4 (3.7%) | 4 (11.4%) | n/a |
Non-ND | 23 (11.5%) | 23 (31.9%) | n/a | 11 (10.2%) | 11 (31.4%) | n/a |